GRACEcast
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
Visit Show Website http://cancerGRACE.org/Recently Aired
-
HD
Do You See Advances in Treatment for Small Cell Lung Cancer in the Near Future?
Research into small cell lung cancer may soon pay off ...
Research into small cell lung cancer may soon pay off in new treatments. Dr. Taofeek Owonikoko of Emory University School of Medicine and the Winship Cancer Institute discusses new approaches that hold great promise. February 2014
-
HD
Will HER2 Inhibitor Drugs Help Lung Cancer Patients?
HER2 inhibitors have been successfully used to combat breast cancer, ...
HER2 inhibitors have been successfully used to combat breast cancer, but research has shown that a small percentage of lung cancer patients have a HER2 mutation as well. Dr. Leena Gandhi talks about the role that HER2 drugs may play to fight lung cancer.
-
HD
Treating Leptomeningeal Carcinomatosis in Lung Cancer
Leptomeningeal carcinomatosis is cancer that has spread to the coating ...
Leptomeningeal carcinomatosis is cancer that has spread to the coating of the brain and spinal cord. In the past, prognosis has been bad. But now doctors are learning of effective treatments to deal with this issue.
-
HD
What is the Northwestern Medical Developmental Therapeutics Institute?
The Northwest Medical Development Therapeutics Institute is breaking new ground ...
The Northwest Medical Development Therapeutics Institute is breaking new ground by conducting clinical trials that will test treatments based on tumor mutations, rather than where the tumor began. Dr. Melissa Johnson describes the work of the center.
-
HD
How Do You Help Your EGFR Patients Make Treatment Decisions When Their Cancers Grow?
Dr. Geoffrey Oxnard of Dana-Farber Cancer Institute describes how he ...
Dr. Geoffrey Oxnard of Dana-Farber Cancer Institute describes how he helps his EGFR lung cancer patients make decisions about next steps in treatment when their cancers grow.
-
HD
Immunotherapy Treatments for Kidney Cancer
Dr. Guru Sonpavde highlights the top research news in immunotherapy ...
Dr. Guru Sonpavde highlights the top research news in immunotherapy for kidney cancer from the ASCO 2014 Annual Meeting.
-
HD
Evaluating Biomarkers in Kidney Cancer
Biomarkers can give clues to many predictive and prognostic issues, ...
Biomarkers can give clues to many predictive and prognostic issues, like how a patient may respond to a drug or if a patient's cancer is likely to recur. Dr. Daniel Heng discusses what researchers are learning.
-
HD
Will Combining Immunotherapies Better Fight Kidney Cancer?
Dr. Lauren Harshman discusses what combinations of drugs are being ...
Dr. Lauren Harshman discusses what combinations of drugs are being studied in kidney cancer patients.
-
HD
Cabozantinib for Late Stage Kidney Cancer
Cometriq (cabozantinib) is already approved for thyroid cancer and is ...
Cometriq (cabozantinib) is already approved for thyroid cancer and is showing promise for late stage kidney cancer.
-
HD
Immunotherapy: What Has a Year’s Experience Taught Us Since ASCO 2013?
Drs. Nasser Hanna and Melissa Johnson discuss developments in Immunotherapy ...
Drs. Nasser Hanna and Melissa Johnson discuss developments in Immunotherapy since ASCO 2013.
